Hospital Clínic de Barcelona incorporates an AI platform in Radiology
Hospital Clínic de Barcelona chooses Aidoc’s AI to improve clinical outcomes and utilize the technology to train residents and empower them with AI e1
More news
A new treatment is effective for advanced HER2-low breast cancer
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and1
Why should boys be vaccinated against papilloma as well as girls?
So far, the papillomavirus vaccine schedule in Catalonia has been for girls of 11-12 years old only. However, from next year, the Department of Healt1
How to promote the figure of the clinician-scientist in research centers
IDIBAPS is promoting different programs to facilitate professionals combining patient care with biomedical research or enjoying periods of intensive1
A delegation of European science journalists visits IDIBAPS
On Tuesday, May 31, a group of 9 journalists visited the Institute to learn about the research being carried out.
How have treatments for hepatocellular carcinoma improved?
Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which they1
Anna Novials receives the Josep Trueta 2022 Award from the Academy
The award, granted by the Academy of Medical and Health Sciences of Catalonia and the Balearic Islands, recognizes Novials' research career in the fi1
New study shows genes can predict response to arthritis treatment and paves the way for future drug development
Researchers from Hospital Clínic-IDIBAPS have participated in the work published by the journal Nature Medicine.
IDIBAPS and EUROIMMUN sign a new agreement on research into neuronal inflammatory diseases
The IDIBAPS research group Pathogenesis of neuronal autoimmune diseases, led by Josep Dalmau, and the company EUROIMMUN Medizinische Labordiagnostika1
Dr. Joan Bartra: “Although we are getting better at controlling allergic disease, we are still a long way from finding a cure”
Respiratory allergy affects around 25% of the general population, especially in spring, at the height of the pollen season. We talk to Dr. Joan Bartr1